Corporate
A scientifically rigorous CRO built for complex preclinical decision-making
Pharmidex Pharmaceutical Services Ltd is a UK-based contract research organisation specialising in the generation of high-quality, regulator-ready preclinical data to support confident programme progression.
Since 2002, we have worked at the interface of discovery, translational science, and regulatory development, supporting clients where scientific uncertainty, regulatory expectations, and time pressure converge.
Our role is not simply to execute studies, but to help sponsors reduce risk, interpret results, and move forward with clarity.
Our Role in the Development Ecosystem
Our Role in the Development Ecosystem
Drug development rarely fails due to lack of data it fails due to poor decisions made on the wrong data.
Pharmidex exists to address this gap.
We support:
- Early-stage biotech companies navigating first-in-human pathways
- Pharmaceutical organisations progressing assets through preclinical development
- Academic and grant-funded consortia translating innovation toward clinical relevance
Across each, our focus remains the same:
generate data that stands up to scrutiny and genuinely informs next steps.
Scientific Depth, Not Just Capacity
Pharmidex is deliberately structured around senior scientific leadership, not volume-driven execution.
Our programmes are shaped by experienced scientists with backgrounds across pharmaceutical R&D, CRO environments, and academic research. This ensures that study design, interpretation, and troubleshooting are guided by judgement — not templates.
Key areas of expertise include:
- CNS, oncology, metabolic and respiratory disease research
- Integrated in vivo pharmacology and translational models
- ADME, PK, toxicokinetics, and exposure-response analysis
- GLP-accredited bioanalysis and safety support
Every programme is tailored to the asset, modality, and regulatory context.
Integrated Capability with Regulatory Awareness
Pharmidex provides integrated preclinical services across in-life, formulation, and bioanalysis, enabling streamlined delivery and reduced operational risk.
Our infrastructure and quality systems support both regulated and non-regulated studies, with a strong understanding of how preclinical data feeds into:
- IND and CTA submissions
- Scientific advice interactions
- Internal portfolio decision-making
This integration allows us to identify issues earlier, reduce rework, and maintain continuity from study design through reporting.
Track Record & Institutional Credibility
Over more than two decades, Pharmidex has delivered 16,000+ studies for 400+ clients across the global life sciences community.
Our work has contributed to a wide range of public and private research initiatives, including major UK and EU-funded programmes (FP6, FP7, Horizon 2020, Innovate UK, MRC), as well as confidential industry-sponsored research.
This breadth of experience has shaped a delivery model that balances scientific ambition with operational realism.
Partnerships Built on Trust and Continuity
Many of our client relationships span multiple programmes and years.
This continuity reflects:
- Consistent scientific standards
- Transparent communication and reporting
- Willingness to challenge assumptions constructively
- Reliability under time and regulatory pressure
We view partnership as a long-term commitment to scientific quality and shared outcomes, not a transactional service.
Quality, Governance & Compliance
Quality and data integrity underpin every aspect of our work.
Pharmidex operates robust governance and QA frameworks aligned with GLP, GCP, and regulatory expectations, supported by experienced quality professionals and auditable systems.
Our facilities, processes, and culture are designed to support both flexibility and compliance without compromise.
Pharmidex facilities are accredited by:
Pharmidex are a proud member of:
Engage With Us
If you are seeking a CRO partner who combines scientific judgement, regulatory awareness, and integrated delivery, we welcome the opportunity to discuss your programme.
➡️
Start a conversation with our scientific team
